The top healthcare stories this week include the UK's first critical care roof garden, Snowflake's clinical AI and Europe's regulations for animal testing…

DIOSynVax is advancing a new frontier in vaccine development, leveraging AI to create broader, longer-lasting protection against evolving viral threats…

ASUS’s integrated platform connects the Handheld Ultrasound DuoScan and VivoWatch 6 Plus to allow frontline medical staff to take instant clinical action…

The strategic collaboration combines clinical data with advanced cloud engineering to improve patient outcomes and support complex medical decision-making…

More News

Featured

Pfizer secures expanded EU approval for a once-weekly haemophilia treatment, widening care options for patients aged 12 and older across Europe…

Read more

UK Parliament’s Women and Equalities Committee warns against ā€˜financial half measures’ in women and girls health, urging stronger NHS investment and action…

Read more
Featured

WHO Member States back precision medicine, while AstraZeneca and Johnson & Johnson advance targeted treatments and personalised healthcare worldwide…

Read more
Featured

UK universities including Imperial College London and more are leading a Ā£3m (US$4m) osteoarthritis study to improve personalised treatments & diagnosis…

Read more
Featured

Google and Essity warn menopause is driving senior women from work, threatening leadership pipelines and costing businesses billions globally…

Read more
Featured

Mitie becomes a central partner at Macclesfield campus, one of AstraZeneca’s most significant global manufacturing and technology sites…

Read more

UNEP warns pharmaceuticals support health but pollution from their lifecycle threatens ecosystems, water and soil, driving resistence and health risks…

Read more

A new governed reasoning agent on Azure reduces clinical data analysis time from weeks to minutes, allowing key experts to safely evaluate more hypotheses…

Read more

Cactus Life Sciences deploys Microsoft AI agents to cut scientific data extraction times by up to 50%, but retains a secure, human-anchored approach…

Read more
Featured

Deloitte says booming GLP-1 and GIP obesity and diabetes drugs are driving pharma R&D returns, but leaving the industry reliant on few blockbuster assets…

Read more